Using Topology To Revolutionize Atrial Tachycardia Treatment
The project aims to develop and validate a diagnostic tool, Directed Graph Mapping, to enhance the accurate diagnosis and treatment of atrial tachycardia, improving ablation strategies and outcomes.
Projectdetails
Introduction
Atrial tachycardia (AT) is a prevalent form of supraventricular tachycardia that can have detrimental impacts on a person's health. The complexity of anatomical reentry patterns and unclear nomenclature hinders precise diagnosis of AT and makes optimal treatment challenging and error-prone. Suboptimal treatment can result in severe outcomes such as heart failure, stroke, and pacemaker implantation due to overablation-induced atrial dysfunction.
Proposed Solution
In this proposal, we introduce a diagnostic tool called Directed Graph Mapping (DGM), which offers a unique classification system based on clear and precise mathematical criteria using topological principles. This allows for the accurate diagnosis and differentiation of various types of AT.
Features of DGM
- DGM can automatically analyze a given case of AT, providing consistent and reliable results.
- It paves the way for the optimization of the ablation strategy.
- DGM can not only diagnose the current AT but also predict hidden slower ATs, which might appear depending on the chosen ablation target.
By being able to predict the hidden ATs, we can revolutionize the treatment of ATs, as these hidden ATs can be treated already after the measurement of the first anatomical map. Therefore, our tool holds the potential to significantly expedite the ablation procedure.
Study Proposal
We propose to conduct a prospective study involving a minimum of 15 hospitals in Belgium that specialize in AT ablations. This study aims to further validate the effectiveness and sustainability of our proposed solution while involving a broad range of electrophysiologists. We aim to publish our results in a high-impact journal.
Intellectual Property and Market Interest
We secured the intellectual property rights of our proof-of-concept through two patents. By discussing with electrophysiologists, we learned that their interest in DGM influences mapping systems. If they recognize the value of DGM for treating AT, mapping companies may adopt the technology through a licensing agreement, which is the final goal of this proposal.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 30-6-2025 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITEIT GENTpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Translational optoelectronic control of cardiac rhythm in atrial fibrillationThis project aims to develop a shock-free, optoelectronic method for controlling cardiac rhythm in atrial fibrillation using engineered 3D heart models and advanced monitoring systems. | ERC Consolid... | € 1.999.999 | 2023 | Details |
Unique non-invasive pace-mapping system to identify subjects at risk of arrhythmic sudden deathDevelop a non-invasive mapping and pacing system to detect cardiac signals for predicting sudden cardiac death, improving early diagnosis and management of heart disease. | ERC Advanced... | € 2.488.400 | 2022 | Details |
A Chemogenetic Approach for the Treatment of Atrial FibrillationDevelop a targeted, non-destructive chemogenetic treatment for atrial fibrillation to safely modulate cardiac excitability and prevent atrial remodeling. | ERC Proof of... | € 150.000 | 2025 | Details |
Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatmentsThis project aims to understand cardiac electroporation mechanisms to develop methods for effective irreversible and reversible treatments for atrial fibrillation and ischemic heart disease. | ERC Starting... | € 1.500.000 | 2024 | Details |
Engineering vasoactive probes for brain-wide imaging of molecular signalingThis project aims to develop AVATars that convert neurotransmitter signaling into hemodynamic signals for enhanced fMRI, enabling visualization of molecular dynamics in brain function. | ERC Starting... | € 1.492.968 | 2023 | Details |
Translational optoelectronic control of cardiac rhythm in atrial fibrillation
This project aims to develop a shock-free, optoelectronic method for controlling cardiac rhythm in atrial fibrillation using engineered 3D heart models and advanced monitoring systems.
Unique non-invasive pace-mapping system to identify subjects at risk of arrhythmic sudden death
Develop a non-invasive mapping and pacing system to detect cardiac signals for predicting sudden cardiac death, improving early diagnosis and management of heart disease.
A Chemogenetic Approach for the Treatment of Atrial Fibrillation
Develop a targeted, non-destructive chemogenetic treatment for atrial fibrillation to safely modulate cardiac excitability and prevent atrial remodeling.
Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatments
This project aims to understand cardiac electroporation mechanisms to develop methods for effective irreversible and reversible treatments for atrial fibrillation and ischemic heart disease.
Engineering vasoactive probes for brain-wide imaging of molecular signaling
This project aims to develop AVATars that convert neurotransmitter signaling into hemodynamic signals for enhanced fMRI, enabling visualization of molecular dynamics in brain function.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
De ontwikkeling van een slimme katheterDit project ontwikkelt een slimme hartkatheter en een realistisch testplatform om de efficiëntie van katheterablatie te verbeteren, wat leidt tot meer kennis en werkgelegenheid in Zuid-Nederland. | Mkb-innovati... | € 132.538 | 2018 | Details |
CARTBox Cardiale ablatieCART-Tech onderzoekt de haalbaarheid van een nieuwe module voor hun CARTBox-software, gericht op het verbeteren van de effectiviteit en veiligheid van cardiale ablaties door MRI- en CT-beeldanalyse. | Mkb-innovati... | € 20.000 | 2021 | Details |
Transcription Factor Gene Therapy for BradyarrhythmiasPacingCure's TRACTION project aims to optimize and validate BradyTx-01, a gene therapy for cardiac pacing dysfunctions, ensuring safety, efficacy, and a pathway to commercialization. | EIC Transition | € 2.499.968 | 2023 | Details |
Laesy Visualisatie 2.0Het project Laesie Visualisatie 2.0 ontwikkelt software voor verbeterde visualisatie van hartweefsel, wat leidt tot efficiëntere behandeling van hartritmestoornissen en lagere gezondheidskosten. | Mkb-innovati... | € 162.190 | 2020 | Details |
Beeldgestuurde oplossingen in de cardiologie en neurologie. Innovatieve weefselherkenning en 4D-monitoring van resultaten bij patiëntenDit project ontwikkelt een cloudplatform voor 3D-beeldbewerking en 4D-analyse om gepersonaliseerde revalidatie en succesvolle pacemakerimplantaties te verbeteren in cardiologie en neurologie. | Mkb-innovati... | € 262.962 | 2019 | Details |
De ontwikkeling van een slimme katheter
Dit project ontwikkelt een slimme hartkatheter en een realistisch testplatform om de efficiëntie van katheterablatie te verbeteren, wat leidt tot meer kennis en werkgelegenheid in Zuid-Nederland.
CARTBox Cardiale ablatie
CART-Tech onderzoekt de haalbaarheid van een nieuwe module voor hun CARTBox-software, gericht op het verbeteren van de effectiviteit en veiligheid van cardiale ablaties door MRI- en CT-beeldanalyse.
Transcription Factor Gene Therapy for Bradyarrhythmias
PacingCure's TRACTION project aims to optimize and validate BradyTx-01, a gene therapy for cardiac pacing dysfunctions, ensuring safety, efficacy, and a pathway to commercialization.
Laesy Visualisatie 2.0
Het project Laesie Visualisatie 2.0 ontwikkelt software voor verbeterde visualisatie van hartweefsel, wat leidt tot efficiëntere behandeling van hartritmestoornissen en lagere gezondheidskosten.
Beeldgestuurde oplossingen in de cardiologie en neurologie. Innovatieve weefselherkenning en 4D-monitoring van resultaten bij patiënten
Dit project ontwikkelt een cloudplatform voor 3D-beeldbewerking en 4D-analyse om gepersonaliseerde revalidatie en succesvolle pacemakerimplantaties te verbeteren in cardiologie en neurologie.